Reagila ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
21Mitochondrial disease1

21. Mitochondrial disease


Clinical trials : 33 Drugs : 42 - (DrugBank : 32) / Drug target genes : 47 - Drug target pathways : 67
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1EUCTR2021-001268-58-HU
(EUCTR)
06/07/202121/03/2021Investigation of effects of cariprazine in patients with mitochondrial schizophreniaInvestigation of cellbiological effects of cariprazine in patients with mitochondrial schizophrenia Mitochondrial disease associated schizophrenia
MedDRA version: 20.0;Level: PT;Classification code 10039626;Term: Schizophrenia;System Organ Class: 10037175 - Psychiatric disorders;Therapeutic area: Psychiatry and Psychology [F] - Behavioral Disciplines and Activities [F04]
Trade Name: Reagila
Product Name: Reagila
Semmelweis University, STIA-POC-2020NULLAuthorised-recruitment may be ongoing or finishedFemale: yes
Male: yes
10Phase 4Hungary